Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

San-Chi Chen

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 21, 2024
Associations between palliative-care consultations and end-of-life quality in cancer patients' last 6 monthsShan Ting Chen, San Chi Chen, Hsing Jung Lee, et al.
Journal of Orthopaedic Surgery and Research|December 8, 2006
Direct effects of caffeine on osteoblastic cells metabolism: the possible causal effect of caffeine on the formation of osteoporosisYang-Hwei Tsuang, Jui-Sheng Sun, Li-Ting Chen, et al.
Anticancer Research|July 26, 2024
Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal CancersWen-Chi Wu, Chien-Fu Hsu, Ming-Huang Chen, et al.
Hepatology International|November 23, 2024
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapyKuan-Chang Lai, Yen-Hao Chen, Yi-Ping Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 8, 2025
Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinomaChing-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
Cells|February 25, 2022
Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of ResistanceYung-Sheng Chang, Chien-Wei Su, San-Chi Chen, et al.
Oncology Letters|February 14, 2018
PD-L1 expression is associated with p16<sup>INK4A</sup> expression in non-oropharyngeal head and neck squamous cell carcinomaSan-Chi Chen, Peter Mu-Hsin Chang, Hsiao-Jung Wang, et al.
BMC Cancer|January 12, 2022
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching studySan-Chi Chen, Yi-Hsiang Huang, Ming-Huang Chen, et al.
Plos One|August 26, 2016
Correction: Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in TaiwanChung-Jen Teng, Leh-Kiong Huon, Yu-Wen Hu, et al.
Taiwanese Journal of Obstetrics & Gynecology|June 26, 2026
Human epidermal growth factor receptor-2, nectin-4, and trophoblast cell surface antigen-2 expression varies significantly across ovarian cancer histotypesShih-Yao Lin, San-Chi Chen, Nai-Ming Cheng, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 21, 2024
Associations between palliative-care consultations and end-of-life quality in cancer patients' last 6 monthsShan Ting Chen, San Chi Chen, Hsing Jung Lee, et al.
Journal of Orthopaedic Surgery and Research|December 8, 2006
Direct effects of caffeine on osteoblastic cells metabolism: the possible causal effect of caffeine on the formation of osteoporosisYang-Hwei Tsuang, Jui-Sheng Sun, Li-Ting Chen, et al.
Anticancer Research|July 26, 2024
Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal CancersWen-Chi Wu, Chien-Fu Hsu, Ming-Huang Chen, et al.
Hepatology International|November 23, 2024
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapyKuan-Chang Lai, Yen-Hao Chen, Yi-Ping Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 8, 2025
Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinomaChing-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, et al.
Cells|February 25, 2022
Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of ResistanceYung-Sheng Chang, Chien-Wei Su, San-Chi Chen, et al.
Oncology Letters|February 14, 2018
PD-L1 expression is associated with p16<sup>INK4A</sup> expression in non-oropharyngeal head and neck squamous cell carcinomaSan-Chi Chen, Peter Mu-Hsin Chang, Hsiao-Jung Wang, et al.
BMC Cancer|January 12, 2022
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching studySan-Chi Chen, Yi-Hsiang Huang, Ming-Huang Chen, et al.
Plos One|August 26, 2016
Correction: Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in TaiwanChung-Jen Teng, Leh-Kiong Huon, Yu-Wen Hu, et al.
Taiwanese Journal of Obstetrics & Gynecology|June 26, 2026
Human epidermal growth factor receptor-2, nectin-4, and trophoblast cell surface antigen-2 expression varies significantly across ovarian cancer histotypesShih-Yao Lin, San-Chi Chen, Nai-Ming Cheng, et al.
Pageof 7